1. Neurocognitive and hypokinetic movement disorder with features of parkinsonism after BCMA-targeting CAR-T cell therapy
- Author
-
Van Oekelen, Oliver, Aleman, Adolfo, Upadhyaya, Bhaskar, Schnakenberg, Sandra, Madduri, Deepu, Gavane, Somali, and Teruya-Feldstein, Julie
- Subjects
T cells -- Receptors ,Antigen receptors, T cell -- Analysis ,Hypokinesia -- Diagnosis -- Complications and side effects -- Care and treatment ,Multiple myeloma -- Diagnosis -- Care and treatment -- Risk factors ,Parkinson's disease -- Diagnosis -- Care and treatment -- Risk factors ,Biological sciences ,Health - Abstract
B-cell maturation antigen (BCMA) is a prominent tumor-associated target for chimeric antigen receptor (CAR)-T cell therapy in multiple myeloma (MM). Here, we describe the case of a patient with MM who was enrolled in the CARTITUDE-1 trial (NCT03548207) and who developed a progressive movement disorder with features of parkinsonism approximately 3 months after ciltacabtagene autoleucel BCMA-targeted CAR-T cell infusion, associated with CAR-T cell persistence in the blood and cerebrospinal fluid, and basal ganglia lymphocytic infiltration. We show BCMA expression on neurons and astrocytes in the patient's basal ganglia. Public transcriptomic datasets further confirm BCMA RNA expression in the caudate of normal human brains, suggesting that this might be an on-target effect of anti-BCMA therapy. Given reports of three patients with grade 3 or higher parkinsonism on the phase 2 ciltacabtagene autoleucel trial and of grade 3 parkinsonism in the idecabtagene vicleucel package insert, our findings support close neurological monitoring of patients on BCMA-targeted T cell therapies. A progressive movement disorder in a patient with multiple myeloma treated with anti-BCMA CAR-T cells that might have been related to on-target activity in the brain supports prospective neurologic monitoring after BCMA-targeting therapies., Author(s): Oliver Van Oekelen [sup.1] [sup.2] , Adolfo Aleman [sup.1] [sup.2] , Bhaskar Upadhyaya [sup.2] [sup.3] [sup.4] , Sandra Schnakenberg [sup.5] [sup.6] , Deepu Madduri [sup.2] [sup.3] , Somali Gavane [...]
- Published
- 2021
- Full Text
- View/download PDF